J&J、IBD患者さんを支援する取り組み「Dual Control～治療と仕事の両立～」の一環で「I-BUDDY」を始動
Who / What / Where / When
Who
What
- 1. Johnson & Johnson launches 'I-BUDDY' to support IBD patients.
- 2. The initiative is part of 'Dual Control' for balancing treatment and work.
- 3. Over 60% of IBD patients are unaware of 'endoscopic remission'.
- 4. Endoscopic remission reduces symptom worsening risk by 68% for UC patients.
- 5. For CD patients, achieving remission lowers surgery needs by one-third.
- 6. The program emphasizes shared decision-making between patients and healthcare providers.
- 7. 'I-BUDDY' aims to help patients achieve personal goals and improve quality of life.
Where
Unknown (outlet HQ)
topics: Health · language: eng
topics: Health · language: eng
When
published 19 May, 04:00Z
ingested 19 May, 04:54Z
ingested 19 May, 04:54Z
Rewrite
headline was already plain — left unchanged
Retrieved
https://japan.cnet.com/release/31169326/
Everything above is the full audit trail for this article: source, country, timestamps, the original headline, and the model that rewrote it. Nothing is hidden.